Croda subsidiary Sederma has launched BB-Biont, a biomimetic peptide that is aimed at smoothing the appearance of pockmarks on the skin by protecting the microbiome.
The company said that BB-Biont selectively slows the growth of Cutibacterium acnes bacteria and destroys its biofilm to avoid inflammatory skin damage, while simultaneously maintaining the biodiversity of the microbiome.
In tests on two mixed panels over two months of application, Sederma added, it significantly reduced the volume of pockmarks and skin roughness. It is water-soluble and recommended for use at 1%. BB-Biont is also RSPO- and IECIC-compliant.
